Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Sipeki

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|March 15, 2014
Immune dysfunction in cirrhosisNora Sipeki, Peter Antal-Szalmas, Peter L Lakatos, et al.
World Journal of Gastroenterology|May 31, 2024
Non-pancreatic hyperlipasemia: A puzzling clinical entityKrisztina Eszter Feher, David Tornai, Zsuzsanna Vitalis, et al.
World Journal of Gastroenterology|December 11, 2023
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodiesNora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2016
Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infectionTamas Tornai, Zsuzsanna Vitalis, Nora Sipeki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2017
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infectionsIldiko Foldi, Tamas Tornai, David Tornai, et al.
BMC Gastroenterology|March 3, 2021
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort studyDavid Tornai, Peter Antal-Szalmas, Tamas Tornai, et al.
Plos One|March 29, 2018
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patientsGyorgy Kovacs, Nora Sipeki, Boglarka Suga, et al.
Journal of Crohn'S & Colitis|July 19, 2015
Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's DiseasePeter L Lakatos, Nora Sipeki, Gyorgy Kovacs, et al.
World Journal of Gastroenterology|June 17, 2015
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's diseaseNora Sipeki, Laszlo Davida, Eszter Palyu, et al.
Journal of Crohn'S & Colitis|February 13, 2019
Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's DiseaseClaudia Deutschmann, Mandy Sowa, Jayaseelan Murugaiyan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|March 15, 2014
Immune dysfunction in cirrhosisNora Sipeki, Peter Antal-Szalmas, Peter L Lakatos, et al.
World Journal of Gastroenterology|May 31, 2024
Non-pancreatic hyperlipasemia: A puzzling clinical entityKrisztina Eszter Feher, David Tornai, Zsuzsanna Vitalis, et al.
World Journal of Gastroenterology|December 11, 2023
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodiesNora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2016
Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infectionTamas Tornai, Zsuzsanna Vitalis, Nora Sipeki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2017
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infectionsIldiko Foldi, Tamas Tornai, David Tornai, et al.
BMC Gastroenterology|March 3, 2021
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort studyDavid Tornai, Peter Antal-Szalmas, Tamas Tornai, et al.
Plos One|March 29, 2018
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patientsGyorgy Kovacs, Nora Sipeki, Boglarka Suga, et al.
Journal of Crohn'S & Colitis|July 19, 2015
Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's DiseasePeter L Lakatos, Nora Sipeki, Gyorgy Kovacs, et al.
World Journal of Gastroenterology|June 17, 2015
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's diseaseNora Sipeki, Laszlo Davida, Eszter Palyu, et al.
Journal of Crohn'S & Colitis|February 13, 2019
Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's DiseaseClaudia Deutschmann, Mandy Sowa, Jayaseelan Murugaiyan, et al.
Pageof 2